Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page A19-A19, February 1, 2024. Background:Preceding respiratory tract infections (RTI) due to bacteria or virus has been linked to an increasing risk of stroke likely by potentiating an inflammatory immune response, endothelial dysfunction, platelet activation, and coagulopathy. aureusinfected WT).

Stroke 40

Stroke Strokes Outcomes Thrombosis 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATMP62-ATMP62, February 1, 2024. Introduction:Seizures are a common initial manifestation of cerebral venous thrombosis (CVT). The primary outcome was delayed seizure(s), occurring after 7 days from CVT diagnosis.

Thrombosis 40

Thrombosis Risk Factors Hemorrhage Outcomes 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionCerebral sinus venous thrombosis (CSVT) has traditionally been treated medically with systemic anticoagulation. We included studies that reported outcomes following EVT for CSVT.

Thrombosis 40

Thrombosis Outcomes Strokes Stroke 40

Journal of the American Heart Association

FEBRUARY 14, 2025

We compared procedural complications and clinical outcomes among patients <75 years of age (n=99), those 75 to 84 years of age (n=103), and those 85 years of age (n=71). Recent guidelines and trials have expanded the indications for TAVR to include younger patients with structural valve deterioration.

Aortic valve 40

Aortic valve Aortic TAVR Outcomes 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP355-AWP355, February 1, 2025. Stroke outcomes were assessed at 24 hours.Results:Exposure to long wavelength red light resulted in a significant reduction in infarct volume following stroke (mice-red 38.817.6 mm3 vs. mice-white 73.315.0 mm3; p<0.01 vs mice-blue 72.927.9

Stroke 40

Stroke Strokes Thrombosis Outcomes 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWMP59-AWMP59, February 1, 2025. Background and Purpose:External counterpulsation (ECP) is a novel noninvasive method used to improve the perfusion of vital organs, which may benefit ischemic stroke patients. Therefore, 184 patients (97.4%) with moderate neurological deficit (mean NIHSS, 8.2)

Stroke 40

Stroke Strokes Hemorrhage Thrombosis 40

DAIC

MARCH 31, 2025

These results suggest that abelacimab may be safe across the spectrum of bleeding risk and may make it possible to anticoagulate some of the most vulnerable populations who otherwise would not be treated and therefore left unprotected from the risk of stroke. Data from these trials are expected in the second half of 2026.

Atrial Fibrillation 52

Atrial Fibrillation BMI General Cardiology Thrombosis 52

Frontiers in Cardiovascular Medicine

MAY 29, 2024

This study investigates clinical outcomes, aortic remodeling, and abdominal aortic perfusion patterns after TEVAR with the novel Castor device.MethodsFrom November 2020 to June 2023, 29 patients with TBAD involving the LSA were treated with the Castor single-branched stent graft. No in-hospital mortality, paraplegia, or stroke occurred.

Stents 52

Stents Stent Aortic Outcomes 52

Stroke Journal

JANUARY 26, 2025

Stroke, Volume 56, Issue 2 , Page 527-532, February 1, 2025. BACKGROUND:Acute ischemic stroke treatment typically involves tissue-type plasminogen activator (tPA) or tenecteplase, but about 50% of patients do not achieve successful reperfusion. DNase-I, which degrades neutrophil extracellular traps, could improve thrombolytic efficacy.

Hemorrhage 40

Hemorrhage Stroke Strokes Thrombosis 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATMP117-ATMP117, February 1, 2025. Introduction:Despite timely recanalization, some ischemic stroke patients treated with endovascular thrombectomy experience persistent neurological deterioration. Experimental stroke models have indicated a critical role for platelets in this process.

Stroke 40

Stroke Strokes Thrombosis Outcomes 40

Open Heart

JANUARY 6, 2022

Colchicine, a cheap and widely used anti-inflammatory has shown promise in improving cardiovascular outcomes. Results The use of colchicine in patients who underwent PCI significantly reduced MACE outcomes (risk ratio 0.73 (95% CI 0.61 This has been shown to increase the likelihood of further major adverse cardiovascular events (MACE).

Coronary Artery Disease 52

Coronary Artery Disease Thrombosis Stents Stent 52

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP328-AWP328, February 1, 2025. Migraine with aura(MwA) is associated with an increased risk of stroke and adverse vascular outcomes compared to those with migraine without aura (MwoA). Patients with any adverse vascular outcomes before the index ECG were excluded. p < 001).

Atrial Fibrillation 40

Atrial Fibrillation Outcomes Coronary Artery Disease Myocardial Infarction 40

Dr. Smith's ECG Blog

NOVEMBER 15, 2023

Stroke-volume:50 ml. MINOCA may be due to: coronary spasm, coronary microvascular dysfunction, plaque disruption, spontaneous coronary thrombosis/emboli , and coronary dissection; myocardial disorders, including myocarditis, takotsubo cardiomyopathy, and other cardiomyopathies. Left ventricular end-diastolic volume: 99 ml.

Coronary Angiogram 109

Coronary Angiogram Plaque Thrombosis STEMI 109

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. This study aims to investigate the incidence, complications, and outcomes of SAH patients who develop HIT.MethodsICD‐9‐CM and ICD‐10‐CM codes were used to query the National Inpatient Sample for patients with SAH between 2010 and 2019.

Hemorrhage 40

Hemorrhage Aneurysm Outcomes Thrombosis 40

Stroke Journal

NOVEMBER 27, 2024

Stroke, Volume 56, Issue 1 , Page 5-13, January 1, 2025. BACKGROUND:Lack of a dedicated thrombectomy device for cerebral venous thrombosis hinders the recanalization ability of endovascular treatment (EVT). The primary efficacy outcome was the proportion of immediate complete recanalization during EVT.

Thrombosis 40

Thrombosis Stent Stents Hemorrhage 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionPediatric patients presenting with atypical stroke symptoms pose a diagnostic challenge, which often causes delays in management. Around a quarter of pediatric stroke patients will present with new onset seizures.

Pediatrics 40

Pediatrics Stroke Strokes Quality of Life 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATMP85-ATMP85, February 1, 2025. However, long-term outcomes remain poorly described, and the prognostic significance of the radiographic findings is uncertain.Methods:We extracted demographics and clinical variables for all infants with DMVT at our institution from 2007 to 2023.

Thrombosis 40

Thrombosis Hemorrhage Congenital Outcomes 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page A134-A134, February 1, 2024. In severe OHSS, increases in capillary permeability can result in hemoconcentration and hypercoagulability leading to thrombotic events, including stroke and cerebral venous thrombosis. were included from each dataset.

Thrombosis 40

Thrombosis Inpatient Embolism Myocardial Infarction 40

Open Heart

NOVEMBER 28, 2023

Eligible were all aetiological studies evaluating risk of cardiovascular outcomes after exposure to common RTIs within any follow-up duration. to 11.0)), stroke (3.5 (1.2 to 44.9)) and deep venous thrombosis (7.8 (4.3 to 4.9)) and stroke (2.6 (95% Evidence was pooled using random-effects models if data allowed.

Myocardial Infarction 52

Myocardial Infarction COVID-19 Cardiovascular Disease Thrombosis 52

Stroke: Vascular and Interventional Neurology

OCTOBER 2, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue 6 , November 1, 2023. BackgroundProcedural intravenous cangrelor has been proposed as an effective platelet inhibition strategy for stenting in acute ischemic stroke. Similarly, the rate of in‐stent thrombosis was not significantly different between the 2 groups (1.8%

Hemorrhage 40

Hemorrhage Thrombosis Stents Stent 40

DAIC

FEBRUARY 18, 2025

Previous studies about heart valve disease have focused on procedural or device outcomes, and less on patient-centered and disease-related outcomes that are relevant to patients physical and mental well-being and quality of life. tim.hodson Tue, 02/18/2025 - 16:41 Feb. tim.hodson Tue, 02/18/2025 - 16:41 Feb.

Heart Valves 52

Heart Valves Quality of Life Cardiothoracic Outcomes 52

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP39-ATP39, February 1, 2025. Outcomes were assessed at 30- and 90-days. The primary outcome for which the trial was powered was adherence (completing 80% of sessions). Secondary outcomes included percentage of sessions completed and pain/discomfort scores from patient diaries.

Blood Pressure 40

Blood Pressure Thrombosis Outcomes Strokes 40

Journal of Cardiovascular Electrophysiology

DECEMBER 17, 2024

vs. 30.4%, p =0.07) and device related thrombosis (4.5% Results Patients were younger in the combined ( n =72) than in the control group ( n =144, 70.27.3 years, p <0.001) but otherwise comparable with a mean CHA 2 D 2 -VASc score of 4.21.1 and 4.41.2 ( p =0.26) and HAS-BLED score of 2.20.8 and 2.30.7 ( p =0.34). Both major (1.4%

Ablation 40

Ablation Arrhythmia Thrombosis Echocardiogram 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ADP36-ADP36, February 1, 2025. All patients had headache, and funduscopic examination demonstrated papilledema for all patients. All patients had headache, and funduscopic examination demonstrated papilledema for all patients.

Stents 40

Stents Stent Stenosis Angioplasty 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. The suggested DCV pathophysiologic mechanisms involve vascular inflammation and delayed cerebral thrombosis (DCT). Intra‐arterial and intrathecal vasodilators have been reportedly used with variable outcomes.

Thrombosis 40

Thrombosis Risk Factors Research Hemorrhage 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. Seven patients had strokes of any kind, three of which were unrelated to the treatment territory, and two of the remaining 4 were non‐compliant with antiplatelet therapy.

Embolism 40

Embolism Aneurysm Hemorrhage Stent 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. The AKI and non‐AKI groups were assessed for baseline clinical characteristics, interventions, complications, and outcomes. Thus, the objective of this study was to explore the predictors and ramifications of AKI in patients with aneurysmal SAH.

Hemorrhage 40

Hemorrhage Aneurysm Cardiac Arrest Myocardial Infarction 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. The relationship between DSA contrast stagnation and clinical outcomes remains unclear. had a large vessel occlusion. Base size had a weak correlation with AUC (p=0.02) and AUC from peak to 80% clearance (p&lt;0.01).

Blood Pressure 40

Blood Pressure Thrombosis Stroke Strokes 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. She was noted to have incidental left internal jugular (IJ) vein thrombosis for which anticoagulation was held in the setting of recent neurosurgical procedure and SAH. Cerebral vasospasm following EEA has rarely been described.

Blood Pressure 40

Blood Pressure Stenosis Hemorrhage Thrombosis 40

Dr. Smith's ECG Blog

NOVEMBER 14, 2023

Here is that last post: A 90-something with acute stroke. We who know ischemic ECGs know that really when T-wave inversion is specific for coronary thrombosis that it indicates reperfusion of the artery, not active occlusion. Outcome: All 4 serial hs troponin I, out to 6 hours, were undetectable. She has no chest symptoms.

Chest Pain 115

Chest Pain Blog Thrombosis Hospital 115

Cardiology Update

FEBRUARY 11, 2024

The NOTION trial, a pioneering study, sought to compare the long-term clinical and bioprosthesis outcomes of Transcatheter Aortic Valve Implantation (TAVI) versus Surgical Aortic Valve Replacement (SAVR) in patients with severe aortic valve stenosis (AS) at lower surgical risk. No cases of clinical valve thrombosis were reported.

Aortic valve 124

Aortic valve Aortic Outcomes Thrombosis 124

DAIC

MAY 15, 2024

In the meta-analysis of seven randomized trials, published in JSCAI and presented at the 2024 EuroPCR conference in Paris, France, researchers compared the outcomes of 7,785 patients undergoing TAVR (a procedure that delivers a new aortic valve into the heart through a catheter) to those undergoing SAVR for severe aortic stenosis.

Aortic valve 105

Aortic valve TAVR Outcomes Aortic 105

Cardiology Update

FEBRUARY 6, 2024

Stroke stands as a major contributor to global morbidity and mortality, imposing a substantial burden on patients, societies, and healthcare systems worldwide. Within the realm of transcatheter aortic valve replacement (TAVR), stroke emerges as a recognized adverse event, manifesting at various stages during and after the procedure.

TAVR 111

TAVR Stroke Strokes Aortic valve 111

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP299-AWP299, February 1, 2025. Background:Newer Oral Anticoagulants (NOACs) offer potential advantages for patients with cerebral venous sinus thrombosis (CVST). The primary outcome was recurrent thrombotic events during 6-month follow-up. vs 8.0%, P=0.014) and mRS2 (95.1%

Thrombosis 40

Thrombosis Hospital Outcomes Strokes 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionCerebral venous sinus thrombosis (CVST) is a rare form of stroke that usually affects young females especially during pregnancy and the postpartum period. Only studies with sample sizes larger than 10 were included.

Thrombosis 40

Thrombosis Outcomes Cancer Risk Factors 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionCerebral venous thrombosis (CVT) is an uncommon form of stroke with relatively low mortality but higher incidence in younger adults.1–3 The first wave of the COVID‐19 pandemic was defined as January‐May 2020. for Hispanic patients.

Thrombosis 40

Thrombosis Inpatient COVID-19 Atrial Fibrillation 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATMP108-ATMP108, February 1, 2024. Background:Prognostication following cerebral venous thrombosis (CVT) remains challenging. Mortality is an uncommon yet catastrophic outcome after CVT.

Thrombosis 40

Thrombosis Risk Factors Hemorrhage Strokes 40